AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting

Executive Summary

• NeuralCloud Solutions (a subsidiary of AI/ML Innovations) entered a non‑binding agreement with Movesense to pilot the deployment of its MaxYield™ ECG signal‑processing platform and CardioYield™ reporting software in third‑party health systems and affiliated clinics.
• The pilot will use Movesense’s medically certified wearable sensors as the data acquisition layer, with NeuralCloud providing AI‑driven analysis and visualization, aiming to increase ECG/Holter reporting capacity and standardize outputs without adding clinical workload.
• Successful validation could lead to a broader commercial rollout, subject to definitive agreements, regulatory approvals, and pilot results.

Key Details

• Agreement: Non‑binding collaboration agreement signed on February 11, 2026 between NeuralCloud (AI/ML Innovations) and Movesense.
• Pilot Scope: Deployment of MaxYield™ ECG signal‑processing platform and CardioYield™ visualization/reporting software via an existing Movesense client into a third‑party health system and its clinics.
• Objectives:
• Evaluate increased ECG analysis capacity and reporting consistency.
• Enhance clinical throughput and standardize reporting outputs.
• Validate integration of AI‑powered analysis with wearable hardware in real‑world outpatient, ambulatory, and Holter‑style monitoring environments.
• Potential Commercialization: Pilot results will inform a possible commercial rollout; any future agreements will be definitive and subject to regulatory considerations.
• Quotes:
• Paul Duffy, Executive Chairman & CEO, AI/ML Innovations: “This expansion builds logically on the framework we announced in January… advancing toward practical, scalable solutions that address growing monitoring demands in ambulatory care.”
• Jussi Kaasinen, CEO, Movesense: “We see continued value in exploring how NeuralCloud's signal processing and reporting platforms can enhance the utility of our scalable ECG sensing technology.”
• Company Backgrounds:
• Movesense – Finnish ISO 13485‑certified manufacturer of medical‑grade wearable sensors (single‑lead ECG, HR, HRV, motion).
• AI/ML Innovations – Global AI/ML company focused on digital health platforms that convert biometric data into actionable clinical insights.

Notable Quotes

• “By continuing to align NeuralCloud's software platforms with Movesense's device ecosystem, we are advancing toward practical, scalable solutions that address growing monitoring demands in ambulatory care.” – Paul Duffy, Executive Chairman & CEO, AI/ML Innovations
• “This expanded collaboration allows us to further assess integration, performance, and operational fit within healthcare workflows.” – Jussi Kaasinen, CEO, Movesense